Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FFBC
|
Maribeth S Rahe
Director |
BUY
Open market or private purchase
|
Direct | 639 Added 2.04% |
$15,413
$24.12 p/Share
|
Apr 10
2019 |
|
TPL
|
Horizon Kinetics LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 42 Added 0.02% |
$36,711
$874.06 p/Share
|
Apr 10
2019 |
|
ORI
|
Charles J Kovaleski
Director |
BUY
Open market or private purchase
|
Direct | 200 Added 3.34% |
$4,140
$20.7 p/Share
|
Apr 10
2019 |
|
BALY
|
Chatham Asset Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 26,003 Added 0.43% |
$832,096
$32.0 p/Share
|
Apr 10
2019 |
|
PD
|
Howard Wilson
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 50 Added 33.33% |
$1,200
$24.0 p/Share
|
Apr 10
2019 |
|
VCRRX
|
David Keith Truex |
BUY
Open market or private purchase
|
Direct | 394 Added 28.3% |
$9,976
$25.32 p/Share
|
Apr 10
2019 |
|
VCMIX
|
David Keith Truex |
BUY
Open market or private purchase
|
Direct | 353 Added 28.26% |
$9,993
$28.31 p/Share
|
Apr 10
2019 |
|
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 140,230 Reduced 2.77% |
$152,851
$1.09 p/Share
|
Apr 10
2019 |
|
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 124,542 Reduced 0.95% |
$8,556,035
$68.7 p/Share
|
Apr 10
2019 |
|
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 13,146 Reduced 0.1% |
$908,652
$69.12 p/Share
|
Apr 10
2019 |
|
TSLA
|
Antonio J. Gracias
Director |
SELL
Open market or private sale
|
Direct | 15,480 Reduced 74.74% |
$4,273,409
$276.06 p/Share
|
Apr 10
2019 |
|
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.41% |
$1,180,800
$39.36 p/Share
|
Apr 10
2019 |
|
FSLR
|
Mark R Widmar
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 33,371 Reduced 17.95% |
$2,002,260
$60.0 p/Share
|
Apr 10
2019 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 0.15% |
$5,717,000
$57.17 p/Share
|
Apr 10
2019 |
|
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 68,690 Reduced 95.19% |
$5,131,830
$74.71 p/Share
|
Apr 10
2019 |
|
SNPS
|
Steven Walske
Director |
SELL
Open market or private sale
|
Direct | 2,109 Reduced 11.34% |
$246,500
$116.88 p/Share
|
Apr 10
2019 |
|
AMR
|
John E Lushefski
Director |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 15.76% |
$161,590
$58.76 p/Share
|
Apr 10
2019 |
|
AMR
|
Harvey L Tepner
Director |
SELL
Open market or private sale
|
Direct | 750 Reduced 2.9% |
$43,905
$58.54 p/Share
|
Apr 10
2019 |
|
ADBE
|
John E Warnock
Director |
SELL
Open market or private sale
|
Indirect | 1,177 Reduced 0.26% |
$317,166
$269.47 p/Share
|
Apr 10
2019 |
|
WTM
|
Morgan W Davis
Director |
SELL
Open market or private sale
|
Indirect | 412 Reduced 7.36% |
$376,976
$914.99 p/Share
|
Apr 10
2019 |
|
PGTK
|
Fresh Air Investments (Canada) Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 110,000 Reduced 1.76% |
$198,000
$1.8 p/Share
|
Apr 10
2019 |
|
WOW
|
Crestview Partners Iii Gp, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 80,876 Added 0.27% |
$763,469
$9.44 p/Share
|
Apr 09
2019 |
|
TPL
|
Horizon Kinetics LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 36 Added 0.02% |
$29,576
$821.55 p/Share
|
Apr 09
2019 |
|
TGE
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 46,301 Added 6.73% |
$1,133,448
$24.48 p/Share
|
Apr 09
2019 |
|
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 32,991 Reduced 0.65% |
$33,321
$1.01 p/Share
|
Apr 09
2019 |
|
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 21,063 Reduced 0.08% |
$1,427,650
$67.78 p/Share
|
Apr 09
2019 |
|
KNSL
|
Frederick L. Russell Jr.
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 2.06% |
$67,930
$67.93 p/Share
|
Apr 09
2019 |
|
PKDC
|
Whitebox Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 116,000 Reduced 7.57% |
$2,115,840
$18.24 p/Share
|
Apr 09
2019 |
|
TSLA
|
Antonio J. Gracias
Director |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 14.89% |
$356,486
$274.22 p/Share
|
Apr 09
2019 |
|
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.41% |
$1,172,100
$39.07 p/Share
|
Apr 09
2019 |
|
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 82 Reduced 0.0% |
$3,937
$48.01 p/Share
|
Apr 09
2019 |
|
DMS
|
Polar Asset Management Partners Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 72,000 Reduced 3.48% |
$742,320
$10.31 p/Share
|
Apr 09
2019 |
|
LGF-B
|
Daniel E. Sanchez
Director |
SELL
Open market or private sale
|
Direct | 3,214 Reduced 71.07% |
$50,235
$15.63 p/Share
|
Apr 09
2019 |
|
MQY
|
Bank Of America Corp |
SELL
Open market or private sale
|
Indirect | 1,319 Reduced 0.0% |
$18,531
$14.05 p/Share
|
Apr 09
2019 |
|
MQY
|
Bank Of America Corp |
SELL
Open market or private sale
|
Indirect | 500 Reduced 0.0% |
$7,020
$14.04 p/Share
|
Apr 08
2019 |
|
FMN
|
Bank Of America Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 526 Reduced 0.0% |
$7,048
$13.4 p/Share
|
Apr 08
2019 |
|
ZYXI
|
Thomas Sandgaard
President, CEO and Chairman |
SELL
Open market or private sale
|
Indirect | 78,917 Reduced 0.52% |
$376,434
$4.77 p/Share
|
Apr 08
2019 |
|
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 6,600 Reduced 0.09% |
$264,792
$40.12 p/Share
|
Apr 08
2019 |
|
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 335 Reduced 0.01% |
$16,080
$48.0 p/Share
|
Apr 08
2019 |
|
Y
|
William K Lavin
Director |
SELL
Open market or private sale
|
Direct | 518 Reduced 19.36% |
$318,860
$615.56 p/Share
|
Apr 08
2019 |
|
AMR
|
Charles Andrew Eidson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,292 Reduced 5.44% |
$138,735
$60.53 p/Share
|
Apr 08
2019 |
|
AMR
|
James Scott Kreutzer
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 630 Reduced 3.75% |
$38,159
$60.57 p/Share
|
Apr 08
2019 |
|
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 27,525 Reduced 0.54% |
$28,075
$1.02 p/Share
|
Apr 08
2019 |
|
LIN
|
Stephen F Angel
Director |
SELL
Open market or private sale
|
Direct | 54,994 Reduced 24.33% |
$10,144,194
$184.46 p/Share
|
Apr 08
2019 |
|
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 22,648 Reduced 0.17% |
$1,537,799
$67.9 p/Share
|
Apr 08
2019 |
|
MACK
|
22 Nw, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 32,873 Added 2.72% |
$190,992
$5.81 p/Share
|
Apr 08
2019 |
|
MEET
|
Luxor Capital Group, LP |
BUY
Open market or private purchase
|
Indirect | 49,900 Added 0.19% |
$262,973
$5.27 p/Share
|
Apr 08
2019 |
|
NGM
|
Merck & Co., Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,121,683 Added 24.14% |
$65,946,928
$16.0 p/Share
|
Apr 08
2019 |
|
CHCO
|
Tracy W Hylton Ii
Director |
BUY
Open market or private purchase
|
Direct | 130 Added 0.27% |
$10,127
$77.9 p/Share
|
Apr 08
2019 |
|
CHCO
|
Robert D Fisher
Director |
BUY
Open market or private purchase
|
Direct | 140 Added 0.43% |
$10,906
$77.9 p/Share
|
Apr 08
2019 |